🇺🇸 FDA
Patent

US 9644207

Compositions and methods for modulating Tau expression

granted A61PA61P25/00A61P25/28

Quick answer

US patent 9644207 (Compositions and methods for modulating Tau expression) held by Ionis Pharmaceuticals, Inc. expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P25/00, A61P25/28